The Study About Glucose Lowering Effect of Vildagliptin in Type 2 Diabetes Patients Treated With Metformin and a Sulfonylurea.

Next Previous
Trial Profile

The Study About Glucose Lowering Effect of Vildagliptin in Type 2 Diabetes Patients Treated With Metformin and a Sulfonylurea.

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Jul 2015

At a glance

  • Drugs Vildagliptin (Primary) ; Glimepiride; Metformin
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms VISUAL

    • Most Recent Events

    • 10 Jun 2017 Biomarkers information updated
    • 27 May 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 14 Mar 2014 Planned number of patients changed from 230 to 400, as per ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top